Daily Archives: 19th March 2018

Chinas SFDA grants creation permit to TPI anti-diabetic drug Gliclazide Tianyin Pharmaceutical Co.

It really is used when proper dietary adjustment and workout fail to decrease the blood sugar articles or for conditions that are not suitable for insulin therapy. Gliclazide is listed in the National Medical Reimbursement List of China. The acceptance and production permit issuance brought TPI’s portfolio to 58 products in total, 24 which are reimbursed by China’s Government MEDICAL CARE INSURANCE Program.. China’s SFDA grants creation permit to TPI anti-diabetic drug Gliclazide Tianyin Pharmaceutical Co., Inc. Continue reading